| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jun―20 |
Protective Efficacy of pDNA Vaccine Candidate Against SARS-CoV-2 in Syrian Golden Hamsters |
Iman Almansour Alzamil, Serguei Golovan, Jennifer Pickens, Krista Salley, Michael Roberts |
| 2 |
[GO] |
2024―May―14 |
Silver Nanoparticle-Based Drug Delivery Systems in the Fight Against COVID-19: Enhancing Efficacy, Reducing Toxicity, and Improving Drug Bioavailability |
Mehdi Yoosefian, Hanieh Sabaghian |
| 3 |
[GO] |
2023―Nov―27 |
Development of mRNA Nano-Vaccines for COVID-19 Prevention and its Biochemical Interactions with Various Disease Conditions and Age Groups |
Mirza Muhammad Faran Ashraf Baig, Lok Yin Wong, Hongkai Wu |
| 4 |
[GO] |
2022―Aug―03 |
Neurological manifestations of SARS-CoV-2 infections: Toward quantum dots based management approaches |
Faezeh Almasi, Fatemeh Mohammadipanah |
| 5 |
[GO] |
2022―Mar―21 |
Recent highlights on Omicron as a new SARS-COVID-19 variant: evolution, genetic mutation, and future perspectives |
Pooja Khairnar, Mukesh Soni, Mayank Handa, Yassine Riadi, Prashant Kesharwani, Rahul Shukla |
| 6 |
[GO] |
2021―Dec―02 |
Drug Repurposing strategies and key challenges for Covid-19 management |
Shubham Mule, Ajit Singh, Khaled Greish, Amirhossein Sahebkar, Prashant Kesharwani, Rahul Shukla |
| 7 |
[GO] |
2021―Aug―20 |
Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery |
Morteza Rabiei, Soheila Kashanian, Seyedeh Sabereh Samavati, Hossein Derakhshankhah, Shahriar Jamasb, Steven J. P. McInnes |
| 8 |
[GO] |
2020―Nov―19 |
Potential inhibitors of SARS-CoV-2: Recent advances |
Ghazaleh Jamalipour Soufi, Siavash Iravani |
| 9 |
[GO] |
2020―Sep―02 |
Active-site Molecular docking of Nigellidine with nucleocapsid- NSP2-MPro of COVID-19 and to human IL1R-IL6R and strong antioxidant role of Nigella-sativa in experimental rats |
Smarajit Maiti, Amrita Banerjee, Aarifa Nazmeen, Mehak Kanwar, Shilpa Das |
| 10 |
[GO] |
2020―Jul―30 |
Coronavirus disease- COVID-19: New perceptives towards epidemic to pandemic |
Santhosh S.B., Mohamed Sheik Tharik A., Susitra Manjari M., Balakrishnan R.M., Muruganandam N., Chandrasekar M.J.N. |
| 11 |
[GO] |
2020―Jul―23 |
Pharmacotherapy in COVID-19 patients: A review of ACE2-raising drugs and their clinical safety |
Saghir Akhtar, Ibrahim F. Benter, Mohammed I. Danjuma, Suhail A.R. Doi, Syed S. Hasan, Abdella M. Habib |
| 12 |
[GO] |
2020―Jul―09 |
Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19 |
Mohammed Maroof Alvi, Sowmya Sivasankaran, Mahima Singh |
| 13 |
[GO] |
2020―May―13 |
CRISPR-Cas Systems Based Molecular Diagnostic Tool for Infectious Diseases and Emerging 2019 Novel Coronavirus (COVID-19) Pneumonia |
Xiaohong Xiang, Keli Qian, Zhen Zhang, Fengyun Lin, Yang Xie, Yang Liu, Zongfa Yang |
